Skip to Main Content

Author Details

Loredana Puca
Sandra and Edward Meyer Cancer Center
2010
22
18
PMIDPaper TitleJournal TitlePublished Year
37546702The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer.Cancer Res Commun2023
34676924Extracellular Matrix in Synthetic Hydrogel-Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors.Adv Mater2022
35617398Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets.Science2022
34737261Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer.Nat Commun2021
32127465SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy.Mol Cancer Ther2020
33144576Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity.Nat Commun2020
30655535ONECUT2 is a driver of neuroendocrine prostate cancer.Nat Commun2019
30232224A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.Clin Cancer Res2019
29844220Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies.Cold Spring Harb Perspect Med2019
31260412N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.J Clin Invest2019
31592503Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.JCO Precis Oncol2019
30894499Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer.Sci Transl Med2019
29921838Patient derived organoids to model rare prostate cancer phenotypes.Nat Commun2018
28331002Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.Cancer Discov2017
28361223Emerging Variants of Castration-Resistant Prostate Cancer.Curr Oncol Rep2017
28106885c-FLIPL enhances anti-apoptotic Akt functions by modulation of Gsk3β activity.Cell Death Differ2017
26855148Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.Nat Med2016
26641771An emerging role for cytopathology in precision oncology.Cancer Cytopathol2016
27728805N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer.Cancer Cell2016
24687185ο-arrestins - new players in Notch and GPCR signaling pathways in mammals.J Cell Sci2014
23886940ο-arrestin 1 (ARRDC1) and β-arrestins cooperate to mediate Notch degradation in mammals.J Cell Sci2013
20508645c-FLIPL enhances anti-apoptotic Akt functions by modulation of Gsk3β activity.Cell Death Differ2010
  • 1 - 22 of 22

Recommended Authors

George V Thomas
Knight Cancer Institute, Oregon Health and Science University
Career Start Year 2016
Number of shared co-authors 3
Alexandra Corella
Fred Hutchinson Cancer Research Center
Career Start Year 2015
Number of shared co-authors 1
Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 11
Yuliang Wang
The Chinese University of Hong Kong
Career Start Year 2014
Number of shared co-authors 0
Joshua Armenia
Oncology R&D
Career Start Year 2013
Number of shared co-authors 19
Shuai Gao
Center for Personalized Cancer Therapy, University of Massachusetts Boston
Career Start Year 2012
Number of shared co-authors 14
Rahul K Kollipara
McDermott Center for Human Growth and Development.
Career Start Year 2010
Number of shared co-authors 4
Adam G Sowalsky
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 14
Helen He Zhu
Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
Career Start Year 2009
Number of shared co-authors 1
David A Quigley
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 17
Alastair Davies
University of British Columbia
Career Start Year 2008
Number of shared co-authors 18
Anne Haegert
University of British Columbia
Career Start Year 2008
Number of shared co-authors 18
Daniel J Coleman
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2007
Number of shared co-authors 5
Mitchell G Lawrence
Biomedicine Discovery Institute, Monash University
Career Start Year 2005
Number of shared co-authors 8
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 29
Jonathan Chou
University of California san francisco
Career Start Year 2005
Number of shared co-authors 12
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 1
Adam Sharp
The Institute for Cancer Research
Career Start Year 2003
Number of shared co-authors 20
Ilsa Coleman
Fred Hutchinson Cancer Center
Career Start Year 2001
Number of shared co-authors 28
Jiaoti Huang
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 20
Nadia Boufaied
Research Institute of the McGill University Health Centre
Career Start Year 2000
Number of shared co-authors 5
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 26
Joshi J Alumkal
Rogel Cancer Center, University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 24
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 2
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 14
Ian G Mills
Queen's University Belfast
Career Start Year 1997
Number of shared co-authors 8
Peter S Nelson
Fred Hutchinson Cancer Center
Career Start Year 1993
Number of shared co-authors 41
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 47
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 7
Massimo Loda
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 47

Collaborators

Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers 18
Andrea Sboner
Institute for Computational Biomedicine
Co-authored papers 12
Mark A Rubin
University of Bern
Co-authored papers 11
Olivier Elemento
Meyer Cancer Center
Co-authored papers 10
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 10
Rohan Bareja
Case Western Reserve University
Co-authored papers 9
David S Rickman
Meyer Cancer Center
Co-authored papers 7
Francesca Demichelis
University of Trento
Co-authored papers 7
Joanna Cyrta
Paris Sciences Lettres University PSL, Institut CURIE
Co-authored papers 6
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Co-authored papers 6
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Co-authored papers 6
David M Nanus
Sandra and Edward Meyer Cancer Center
Co-authored papers 6
Scott T Tagawa
Meyer Cancer Center, Weill Cornell Medicine-NewYork Presbyterian Hospital
Co-authored papers 6
Davide Prandi
University of Trento
Co-authored papers 5
Michael Sigouros
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 4
Chantal Pauli
University Hospital Zurich
Co-authored papers 4
Cynthia Cheung
Chaminade University of Honolulu
Co-authored papers 4
Yu Chen
School of Pharmacy, University of Wisconsin-Madison
Co-authored papers 4
Rema Rao
Montefiore Medical Center/Albert Einstein College of Medicine
Co-authored papers 4
Aram Vosoughi
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 4
Terra J McNary
Co-authored papers 3
Yuzhuo Wang
University of British Columbia
Co-authored papers 2
Ryan Dittamore
Decipher Biosciences Inc.
Co-authored papers 2
Amina Zoubeidi
University of British Columbia
Co-authored papers 2
Shaham Beg
New York-Presbyterian Hospital-Weill Cornell Medical College
Co-authored papers 2
Martin E Gleave
University of British Columbia
Co-authored papers 2
Bishoy M Faltas
Sandra and Edward Meyer Cancer Center
Co-authored papers 2
Theresa Y MacDonald
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 2
Kenneth Eng
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 2
David Wilkes
Caryl and Israel Englander Institute for Precision Medicine.
Co-authored papers 2
Release 1.2